Guardian Investor Services’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
$1.01M Sell
10,286
-147
-1% -$14.9K 0.8% 24
2014
Q4
$983K Sell
10,433
-290
-3% -$30K 0.78% 26
2014
Q3
$1.14M Sell
10,723
-719
-6% -$70.4K 0.92% 20
2014
Q2
$949K Sell
11,442
-382
-3% -$29.7K 0.73% 29
2014
Q1
$838K Sell
11,824
-442
-4% -$34.7K 0.65% 33
2013
Q4
$922K Buy
12,266
+45
+0.4% +$3.13K 0.7% 32
2013
Q3
$768K Sell
12,221
-146
-1% -$8.73K 0.64% 34
2013
Q2
$633K Buy
+12,367
New +$645K 0.54% 35

Other funds holding GILD

Guardian Investor Services's GILD Position: Q1 2015 in Review

Guardian Investor Services reduced its Gilead Sciences (GILD) stake by 1.4% in Q1 2015, selling an estimated $14.9K and leaving 10,286 shares worth $1.01M. The position accounts for 0.8% of the portfolio, ranked #24.

Guardian Investor Services first reported a position in GILD in Q2 2013 and has held it in 8 quarters since. The position peaked at $1.14M in Q3 2014. 1,493 funds tracked by Wall St. Rank hold GILD as of Q1 2015.

  • Guardian Investor Services held 10,286 shares of Gilead Sciences worth $1.01M as of Q1 2015.
  • Guardian Investor Services sold 147 Gilead Sciences shares in Q1 2015, an estimated $14.9K.
  • Gilead Sciences made up 0.8% of Guardian Investor Services's portfolio in Q1 2015, its #24 holding.
  • Guardian Investor Services first reported a position in Gilead Sciences in Q2 2013 and has held it in 8 quarters since.
  • Guardian Investor Services's Gilead Sciences position peaked at $1.14M in Q3 2014.
  • 1,493 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2015.

Based on Guardian Investor Services's 13F filing for Q1 2015, filed 5 May 2015.